giant cell tumor of bone

Summary

Summary: A bone tumor composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumors range from benign to frankly malignant lesions. The tumor occurs most frequently in an end of a long tubular bone in young adults. (From Dorland, 27th ed; Stedman, 25th ed)

Top Publications

  1. ncbi [Giant cell tumor of bone with rapid malignant course]
    M R Lachat
    , Stadtspital Triemli, , Switzerland
    Orthopade 33:344-8. 2004
  2. ncbi Are fibula strut allografts a reliable alternative for periarticular reconstruction after curettage for bone tumors?
    Peter J Buecker
    Harvard Medical School, Beth Israel Deaconess Medical Center, Children s Hospital Boston, Boston, MA, USA
    Clin Orthop Relat Res 461:170-4. 2007
  3. ncbi Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone
    Isabella W Y Mak
    McMaster University, Hamilton, Ontario, Canada L8V 5C2
    Hum Pathol 41:1320-9. 2010
  4. ncbi Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone
    Isabella W Y Mak
    Department of Surgery, McMaster University, Hamilton, Ontario, Canada
    Bone 45:377-86. 2009
  5. ncbi Cathepsin K is the principal protease in giant cell tumor of bone
    Jan H N Lindeman
    Department of Biomedical Research, TNO Prevention and Health, PO Box 2215, 2301 CE Leiden, The Netherlands
    Am J Pathol 165:593-600. 2004
  6. ncbi Properties of the stromal cell in giant cell tumor of bone
    Michelle Ghert
    McMaster University, Hamilton Health Sciences and the Juravinski Cancer Centre, Hamilton, Ontario, Canada
    Clin Orthop Relat Res 459:8-13. 2007
  7. ncbi Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy
    Wolfgang T Becker
    Orthopädische Klinik Volmarstein, Universitat Witten Herdecke, Wetter, Germany
    J Bone Joint Surg Am 90:1060-7. 2008
  8. ncbi Treatment options for recurrent giant cell tumors of bone
    Maurice Balke
    Department of Orthopedic Surgery, University of Muenster, Albert Schweitzer Str 33, 48149, Munster, Germany
    J Cancer Res Clin Oncol 135:149-58. 2009
  9. ncbi Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone
    Maurice Balke
    Department of Orthopaedic Surgery, University of Munster, Munster, Germany
    BMC Cancer 10:462. 2010
  10. ncbi Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone
    M Alberghini
    Istituto Ortopedico Rizzoli, Bologna, Italy
    Virchows Arch 456:97-103. 2010

Research Grants

  1. Molecular Mechanisms in Bone Resorption
    STEVEN LIETMAN; Fiscal Year: 2009
  2. RANK-Associated Inhibitor (RAIN) in Osteoclast Formation
    Bryant Darnay; Fiscal Year: 2007
  3. Bioengineering Annulus Fibrosus using Silk Scaffold
    Rita Kandel; Fiscal Year: 2006
  4. Molecular Mechanisms of Ectopic Bone Formation
    STEVEN LIETMAN; Fiscal Year: 2006
  5. METABOLISM IN NORMAL AND OSTEOARTHRITIC CARTILAGE
    Henry Mankin; Fiscal Year: 1991
  6. Minimally Invasive Approaches for Craniofacial Surgery
    Maria Troulis; Fiscal Year: 2005
  7. INVESTIGATING THE MECHANISMS OF PRB TUMOR SUPPRESSION
    Arnab Chakravarti; Fiscal Year: 2003
  8. METABOLISM IN NORMAL AND OSTEOARTHRITIC CARTILAGE
    Henry Mankin; Fiscal Year: 2001
  9. Molecular Mechanisms in Bone Resorption
    Steven A Lietman; Fiscal Year: 2010

Detail Information

Publications186 found, 100 shown here

  1. ncbi [Giant cell tumor of bone with rapid malignant course]
    M R Lachat
    , Stadtspital Triemli, , Switzerland
    Orthopade 33:344-8. 2004
    ..Following the diagnosis of giant cell tumor of bone (GCT) on biopsy and curettage, a rapid malignant course was observed with recurrence 2.5 months later...
  2. ncbi Are fibula strut allografts a reliable alternative for periarticular reconstruction after curettage for bone tumors?
    Peter J Buecker
    Harvard Medical School, Beth Israel Deaconess Medical Center, Children s Hospital Boston, Boston, MA, USA
    Clin Orthop Relat Res 461:170-4. 2007
    ....
  3. ncbi Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone
    Isabella W Y Mak
    McMaster University, Hamilton, Ontario, Canada L8V 5C2
    Hum Pathol 41:1320-9. 2010
    b>Giant cell tumor of bone (GCT) is an aggressively osteolytic primary bone tumor that is characterized by the presence of abundant multinucleated osteoclast-like giant cells, hematopoietic monocytes, and a distinct mesenchymal stromal cell ..
  4. ncbi Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone
    Isabella W Y Mak
    Department of Surgery, McMaster University, Hamilton, Ontario, Canada
    Bone 45:377-86. 2009
    b>Giant Cell Tumor of bone (GCT) is an aggressively osteolytic and cytokine-rich bone tumor...
  5. ncbi Cathepsin K is the principal protease in giant cell tumor of bone
    Jan H N Lindeman
    Department of Biomedical Research, TNO Prevention and Health, PO Box 2215, 2301 CE Leiden, The Netherlands
    Am J Pathol 165:593-600. 2004
    ..Inhibition of cathepsin K or its associated proton-pump may provide new therapeutic opportunities for GCT...
  6. ncbi Properties of the stromal cell in giant cell tumor of bone
    Michelle Ghert
    McMaster University, Hamilton Health Sciences and the Juravinski Cancer Centre, Hamilton, Ontario, Canada
    Clin Orthop Relat Res 459:8-13. 2007
    ..The spindle like stromal cells of GCT have characteristics of osteoblast progenitors and produce active matrix-degrading proteases. These cells may therefore play a central role in bone destruction...
  7. ncbi Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy
    Wolfgang T Becker
    Orthopädische Klinik Volmarstein, Universitat Witten Herdecke, Wetter, Germany
    J Bone Joint Surg Am 90:1060-7. 2008
    The use of adjuvants after curettage has been well established for the treatment of giant cell tumor of bone. The purpose of this study was to analyze the rates of recurrence following different types of treatment as well as the influence ..
  8. ncbi Treatment options for recurrent giant cell tumors of bone
    Maurice Balke
    Department of Orthopedic Surgery, University of Muenster, Albert Schweitzer Str 33, 48149, Munster, Germany
    J Cancer Res Clin Oncol 135:149-58. 2009
    ..The possible surgical procedures range from repeated intralesional curettage to wide resection...
  9. ncbi Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone
    Maurice Balke
    Department of Orthopaedic Surgery, University of Munster, Munster, Germany
    BMC Cancer 10:462. 2010
    ..GCTB frequently recurs and can produce metastatic lesions in the lungs. Bisphosphonates are anti-resorptive drugs which act mainly on osteoclasts...
  10. ncbi Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone
    M Alberghini
    Istituto Ortopedico Rizzoli, Bologna, Italy
    Virchows Arch 456:97-103. 2010
    ..Our findings suggest that most lung nodules associated with primary conventional GCTBs are implants derived from tumour emboli formed in areas of haemorrhage and thrombus formation within the primary tumour...
  11. ncbi Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study
    Lung Fung Tse
    Department of Orthopaedics and Traumatology, Prince of Wales Hospital, Shatin, Hong Kong
    Bone 42:68-73. 2008
    ..Therefore our clinical study aims to investigate whether the administration of bisphosphonate as an adjuvant can further decrease local recurrence following the surgical treatment of GCT of bone...
  12. ncbi Giant cell tumor of bone: treatment and outcome of 214 cases
    Maurice Balke
    Department of Orthopedic Surgery, University of Muenster, Muenster, Germany
    J Cancer Res Clin Oncol 134:969-78. 2008
    Two hundred and fourteen patients with benign giant cell tumor of bone (GCTB), treated from 1980 to 2007 at the Department of Orthopedics of the University of Muenster (Germany), were analyzed in a retrospective study.
  13. ncbi Multicentric giant cell tumor of bone: ten lesions at presentation
    Il-Hyung Park
    Department of Orthopaedic Surgery, Kyungpook National University Hospital, 50 Samduk, Chung-gu, 700-721 Taegu, Korea (South
    Skeletal Radiol 32:526-9. 2003
    The case of a 19-year-old man with multicentric and subsequent metachronous giant cell tumor of bone is presented. Ten lesions were identified at presentation and eventually two more lesions developed...
  14. ncbi [Giant cell tumor of bone and malignancies in giant cell tumor: a clinicopathologic analysis]
    Li hua Gong
    Department of Pathology, Beijing Jishuitan Hospital, Beijing 100035, China
    Zhonghua Bing Li Xue Za Zhi 38:312-5. 2009
    ..To study the clinicopathologic features, diagnosis and differential diagnosis of malignancies in giant cell tumor (MGCT)...
  15. ncbi Malignancy in giant cell tumor of bone
    Franco Bertoni
    Istituto Ortopedico Rizzoli, Bologna, Italy
    Cancer 97:2520-9. 2003
    ..The goals of the current study were to define the clinicopathologic and histologic features of malignancy in giant cell tumors and to clarify the terminology...
  16. ncbi Aneurysmal bone cyst and giant cell tumor of bone of the hand and distal radius
    Edward A Athanasian
    Hospital for Special Surgery, 535 East 70th Street, New York, New York 10021, USA
    Hand Clin 20:269-81, vi. 2004
    Aneurysmal bone cyst and giant cell tumor of bone have historically been considered benign lesions that can behave in locally aggressive fashion. The clinical and pathologic findings share some common characteristics...
  17. ncbi Impact severity of local recurrence in giant cell tumor of bone
    Richard L McGough
    From the University of Texas M.D. Anderson Cancer Center, Department of Orthopaedic Oncology, Houston, TX
    Clin Orthop Relat Res 438:116-22. 2005
    ..Despite its benign histology, giant cell tumor of bone is an aggressive tumor that demands meticulous attention to surgical detail and close postoperative ..
  18. ncbi Thapsigargin potentiates TRAIL-induced apoptosis in giant cell tumor of bone
    Lin Huang
    Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Shatin, N.T, Hongkong SAR, China
    Bone 34:971-81. 2004
    ..In this study, we examined the potentiation of TRAIL-induced apoptosis in the stromal-like tumor cells of giant cell tumor of bone (GCT)...
  19. ncbi Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft
    W Zhen
    Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, Xian City, Shannxi, China
    J Bone Joint Surg Br 86:212-6. 2004
    ..Three had moderate function, and three needed amputation. Our findings indicate that treatment with an aqueous solution of zinc chloride and reconstructive bone grafting after curettage gives good results...
  20. ncbi [Giant cell tumor of bone. An evaluation of 87 patients]
    P U Tunn
    Klinik fur Chirurgie und Chirurgische Onkologie, Charite Universitatsmedizin Berlin
    Z Orthop Ihre Grenzgeb 141:690-8. 2003
    ..Giant cell tumor (GCT) of bone is a very peculiar and interesting tumor due to of its biological behavior and the phenomenon of pulmonary metastases of a histologically benign tumor. We present the results of a retrospective study...
  21. ncbi Metastatic giant cell tumor of bone: are there associated factors and best treatment modalities?
    Seethalakshmi Viswanathan
    Department of Pathology, Tata Memorial Hospital, Parel, Mumbai 400012, India
    Clin Orthop Relat Res 468:827-33. 2010
    ..Although the overall outcome was favorable, metastasectomy is recommended where feasible. LEVEL OF EVIDENCE: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence...
  22. ncbi Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions
    S M Kumta
    Department of Orthopaedics and Traumatology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, N T Hongkong, China
    Life Sci 73:1427-36. 2003
    ..the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) in giant cell tumor of bone (GCT) and other osteolytic lesions in bone...
  23. ncbi Radiotherapy in the management of giant cell tumor of bone
    Jimmy J Caudell
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 57:158-65. 2003
    PURPOSE: To evaluate the outcomes of patients with giant cell tumor of bone (GCTB) treated with radiotherapy (RT) with or without surgical resection...
  24. ncbi Giant cell tumor of bone express p63
    Brendan C Dickson
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
    Mod Pathol 21:369-75. 2008
    ..The purpose of this study was to investigate p63 expression in giant cell tumor of bone and to determine whether it can be used to discriminate between other giant cell-rich tumors...
  25. ncbi Giant cell tumour of bone
    David M Thomas
    Departments of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
    Curr Opin Oncol 21:338-44. 2009
    ..Giant cell tumour of bone (GCT) is the most common benign bone tumour and afflicts a young population. Treatment options for patients with unresectable disease have remained fairly static for the past three decades...
  26. ncbi Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years
    Aarne H Kivioja
    Department of Orthopedics and Traumatology, Helsinki University Central Hospital, Helsinki, Finland
    Acta Orthop 79:86-93. 2008
    ..Giant cell tumors of bone rarely metastasize but often recur locally after surgery. There is limited knowledge about the risk of recurrence related to different types of treatment...
  27. ncbi Histogenetic characterization of giant cell tumor of bone
    Manuela Salerno
    Laboratory for Pathophysiology, Istituto Ortopedico Rizzoli, 40136 Bologna, Italy
    Clin Orthop Relat Res 466:2081-91. 2008
    ..The increased number of giant cells in GCT may be secondary to an autocrine circuit mediated by the receptor activator of nuclear factor kB...
  28. ncbi Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature
    Olarn Arpornchayanon
    Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
    J Med Assoc Thai 91:1609-12. 2008
    ..The patient's gait was normal. From the present study, the authors demonstrate the effectiveness of zoledronate for treatment of giant cell tumor at the sacrum. It can reduce the morbidity from major surgery...
  29. ncbi Giant cell tumour of bone: morphological, biological and histogenetical aspects
    Mathias Werner
    Institute of Osteopathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Int Orthop 30:484-9. 2006
    ..Further research of the pathogenesis of GCT as well as the complex interactions of its cellular populations may provide the knowledge necessary for developing approaches for a biological-based therapy of this neoplasm...
  30. ncbi Multicentric giant cell tumor of bone. Clinicopathologic analysis of thirty cases
    Benjamin Hoch
    Mayo Clinic, Rochester, MN 55905, USA
    J Bone Joint Surg Am 88:1998-2008. 2006
    b>Giant cell tumor of bone accounts for 4% to 5% of primary bone tumors. Approximately 1% of cases present as multiple synchronous or metachronous lesions...
  31. ncbi Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution
    M Dominkus
    University Clinic of Vienna, Department of Orthopaedics, Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
    Int Orthop 30:499-504. 2006
    ..We conclude that even metastatic benign giant cell tumours have an excellent prognosis after adequate resection. No prognostic factors despite high-grade lesions were detectable...
  32. ncbi Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy
    F Malek
    San Francisco Department of Orthopaedic Surgery UCSF Comprehensive Cancer Center Orthopaedic Oncology Service, University of California, San Francisco, CA 94115 1939, USA
    Int Orthop 30:495-8. 2006
    ..In cases where more resources are available, the addition of adjuvant therapies, as noted in the recent literature, may be beneficial. The results of this study should be considered when designing multicenteric studies in the future...
  33. ncbi Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study
    F Vult von Steyern
    Department of Orthopaedics, Lund University Hospital, SE 221 85 Lund, Sweden
    J Bone Joint Surg Br 88:531-5. 2006
    ....
  34. ncbi Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis
    Linda Moskovszky
    1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Ulloi ut 26, Budapest 1085, Hungary
    Genes Chromosomes Cancer 48:468-79. 2009
    Genetic instability in relation to clinical behavior was studied in 52 cases of giant cell tumor of bone (GCTB). Ploidy was determined in the mononuclear cell population by using native cell smears and image cytometry...
  35. ncbi Giant cell tumor of bone
    William M Mendenhall
    Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA
    Am J Clin Oncol 29:96-9. 2006
    ..To discuss the treatment and outcomes for giant cell tumor (GCT) of bone...
  36. ncbi Giant cell tumor of bone
    Robert E Turcotte
    Division of Orthopaedic Surgery, McGill University, Montreal, Quebec, Canada
    Orthop Clin North Am 37:35-51. 2006
    ..Preferred treatment usually consists of extensive curettage and filling of the cavity with bone graft or cement. Debate still exists about the usefulness of local adjuvant treatment. Functional outcome is usually very good...
  37. ncbi Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue
    Yu Sin Lau
    Department of Pathology, University of Oxford, Nuffield Orthopaedic Centre, OX3 7LD Oxford, UK
    Hum Pathol 36:945-54. 2005
    ..Inhibitors of osteoclast formation and activity are likely to be effective in controlling the osteolysis associated with GCTB and possibly other giant-cell-rich lesions...
  38. ncbi Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations
    Ludmila Gorunova
    Department of Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    Genes Chromosomes Cancer 48:583-602. 2009
    b>Giant cell tumor of bone (GCTB) is a benign but locally aggressive tumor with metastatic potential. We performed cytogenetic analysis on 101 GCTB from 92 patients...
  39. ncbi Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB
    Teresa Morgan
    Ian Potter Foundation Center for Cancer Genomics and Predictive Medicine and Research Division, Peter MacCallum Cancer Center, Melbourne, Australia
    Am J Pathol 167:117-28. 2005
    b>Giant cell tumor of bone (GCT) is a generally benign, osteolytic neoplasm comprising stromal cells and osteoclast-like giant cells...
  40. ncbi Primary malignant giant-cell tumor of bone has high survival rate
    Stepan V Domovitov
    Orthopaedic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
    Ann Surg Oncol 17:694-701. 2010
    ..This study compared malignant to benign GCTs and defined the clinical outcome of the patients in a large series of case-matched patients from a single institution...
  41. ncbi Cytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administration
    Yuen-Y Cheng
    Department of Orthopaedics and Traumatology, Chinese University of Hong Kong, Hong Kong, China
    Ultrastruct Pathol 27:385-91. 2003
    b>Giant cell tumor of bone (GCT) is a local aggressive neoplasm of bone characterized by expansive osteolytic lesions at the epiphysis of long bones...
  42. ncbi Complications associated with bone cementing for the treatment of giant cell tumors of bone
    Takuro Wada
    Department of Orthopaedic Surgery, Sapporo Medical University, South-1, West-16, Sapporo 060-8543, Japan
    J Orthop Sci 7:194-8. 2002
    ..Acrylic cement reconstruction is a safe and effective procedure that provides local adjuvant therapy. Giant cell tumors with an associated intraarticular fracture remain a challenging problem to treat...
  43. ncbi De novo malignant transformation of giant cell tumor of bone
    T Marui
    Department of Orthopaedic Surgery, Kobe University School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
    Skeletal Radiol 30:104-8. 2001
    ..In both patients, radiation and never been given. Malignant transformation has rarely been reported in patients with GCT of bone who have not received radiation treatment...
  44. ncbi Giant cell tumor of bone: a clinicopathologic study of prognostic factors
    F Masui
    Department of Pathology, Jikei University School of Medicine, Tokyo, Japan
    Pathol Int 48:723-9. 1998
    Forty-seven cases of giant cell tumor of bone were clinicopathologically reviewed to determine any useful prognostic factors. Disease recurred in 11 cases...
  45. ncbi Megavoltage radiation therapy for axial and inoperable giant-cell tumor of bone
    A Chakravarti
    Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    J Bone Joint Surg Am 81:1566-73. 1999
    ..We performed the present study to evaluate the efficacy of megavoltage radiation in terms of lack of tumor progression and treatment-related morbidity...
  46. ncbi Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization
    Patrick P Lin
    Section of Orthopaedic Oncology, M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 95:1317-25. 2002
    ..The goal of this study is to evaluate the long-term outcome of selective arterial embolization as an alternative treatment modality...
  47. ncbi Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
    David Thomas
    Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia
    Lancet Oncol 11:275-80. 2010
    ..We investigated the potential therapeutic effect of denosumab, a fully human monoclonal antibody against RANKL, on tumour-cell survival and growth in patients with GCT...
  48. ncbi Giant cell tumor of bone: an immunohistochemical comparative study
    F Masui
    Department of Pathology, Jikei University School of Medicine, Tokyo, Japan
    Pathol Int 48:355-61. 1998
    ....
  49. ncbi Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group
    R Sciot
    Department of Pathology, University of Leuven, Belgium
    Mod Pathol 13:1206-10. 2000
    Aneurysmal bone cyst and giant cell tumor of bone are relatively rare bone tumors that sometimes coexist. We examined the karyotypes of 3 aneurysmal bone cysts, 12 giant cell tumors, and 3 combined lesions...
  50. ncbi Osteoclast-type giant cell neoplasm of salivary gland. A microdissection-based comparative genotyping assay and literature review: extraskeletal "giant cell tumor of bone" or osteoclast-type giant cell "carcinoma"?
    Loretta L Y Tse
    Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China
    Am J Surg Pathol 28:953-61. 2004
    Primary salivary gland tumors resembling giant cell tumor of bone are very rare and have unsettled histogenesis. Both mesenchymal and epithelial origins have been suggested...
  51. ncbi Giant-cell tumors of bone: an analysis of 87 cases
    Yu-Ping Su
    Department of Orthopaedics and Traumatology, Veterans General Hospital, 201, Sec. 2, Shih-Pai Road, 112, Taipei, Taiwan, ROC
    Int Orthop 28:239-43. 2004
    ..Functional outcome was evaluated using the Enneking scoring system. Average rating was 86% for the lower extremity and 83% for the upper extremity. The overall satisfactory rate was 88%...
  52. ncbi Recurrent giant cell tumor of bone with simultaneous regional lymph node and pulmonary metastases
    Sajid S Qureshi
    Department of Bone and Soft Tissue, Tata Memorial Hospital, E. Borges Road, Parel, Bombay, India
    Skeletal Radiol 34:225-8. 2005
    ..In this case report we document a case of giant cell tumor of the patella in which, associated with local recurrence, there were simultaneous metastases to lymph nodes and lungs...
  53. ncbi Ethanol as a local adjuvant for giant cell tumor of bone
    Kevin B Jones
    Department of Orthopaedics and Rehabilitation, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, 01051 John Pappajohn Pavilion, Iowa City, IA 52242, USA
    Iowa Orthop J 26:69-76. 2006
    ..Until such evidence becomes available, the use of adjuvant ethanol offers a compromise between higher toxicity adjuvants and no chemical adjuvant at all...
  54. ncbi Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone
    Ted S Liao
    Center for Orthopaedic Research, Department of Orthopaedic Surgery, Columbia University, 622 W. 168th Street, BHN816, New York, NY 10032, USA
    J Orthop Res 23:203-9. 2005
    ..These results suggest that SDF-1 is one of the significant chemoattractant factors involved in the recruitment of hematopoietic osteoclast precursor cells during tumor-induced osteoclastogenesis...
  55. ncbi Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone
    Y Y Cheng
    Department of Orthopaedics and Traumatology, Chinese University of Hong Kong, Shatin, N.T, Hong Kong SAR
    Calcif Tissue Int 75:71-7. 2004
    ..41% at 150 microM, followed by pamidronate (22.23%) and alendronate (15.3%). Our observations suggest that these drugs may be considered as potential adjuvants in the treatment of GCT...
  56. ncbi Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant
    Joo Han Oh
    Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seoul, South Korea
    Int Orthop 30:490-4. 2006
    ..Recurrence-free probability was 87.6% at final follow-up (13 years) after index surgery by Kaplan-Meyer analysis. Our data suggest that anhydrous alcohol can be used as an effective safe adjuvant for the treatment of GCT of long bone...
  57. ncbi Multiple skeletal metastases from a giant cell tumour of the distal fibula with fatal outcome
    C I Leichtle
    Orthopaedic Department, , Hoppe-Seyler-Str. 3, , Germany
    J Bone Joint Surg Br 88:396-9. 2006
    ..After a second recurrence and six years after the initial diagnosis, she rapidly developed multiple bony metastases. The outcome was fatal...
  58. ncbi Periacetabular limb salvage for malignant bone tumours
    A Asavamongkolkul
    Department of Orthopaedic Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
    J Orthop Surg (Hong Kong) 13:273-9. 2005
    ..To evaluate treatment outcomes in primary malignant periacetabular bone tumour removal and limb salvage with or without bone-graft reconstruction...
  59. ncbi Reconstruction following en bloc resection of a giant cell tumor of the distal radius using a vascularized pedicle graft of the ulna
    C S Intuwongse
    Department of Orthopaedic Surgery, Institute of Orthopaedics, Lerd Sin General Hospital, Bangkok, Thailand
    J Hand Surg Am 23:742-7. 1998
    ..It provides early bone union and improves stability of the wrist joint. Four cases of giant cell tumor were treated and all 4 cases had satisfactory results...
  60. ncbi Treatment of giant cell tumors with allograft transplants: a 30-year study
    Henry J Mankin
    Orthopaedic Oncology Service, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Orthop Relat Res 439:144-50. 2005
    ....
  61. ncbi Primary giant cell tumours of the digital bones of the hand
    M Ropars
    London Bone Tumour Unit, The Royal National Orthopaedic Hospital, Stanmore, Middlesex, London, UK
    J Hand Surg Eur Vol 32:160-4. 2007
    ..Our small series of cases supports a policy of aggressive primary surgery, including amputation or en bloc resection and reconstruction...
  62. ncbi Microsurgical fibular flap for pelvic ring reconstruction after periacetabular tumor resection
    Guangrong Yu
    Department of Orthopedic Surgery, Tongji University, Tongji Hospital, Shanghai, China
    J Reconstr Microsurg 23:137-42. 2007
    ..This report shows our experience in use of microsurgical fibular flaps for arthrodesis of the hip after periacetabular tumor resection, which restores the continuity of the pelvic ring with minimal shortening of the limb...
  63. ncbi [Functional reconstruction of the radial articular surface after giant cell tumor]
    I Warnecke
    Klinik für Plastische, Rekonstruktive und Asthetische Chirurgie, Handchirurgie, Städtisches Klinikum Bielefeld Mitte, Bielefeld
    Orthopade 36:679-82. 2007
    ....
  64. ncbi Tibial giant cell tumor with distant subcutaneous metastasis
    Rajendra S Garbyal
    Acta Cytol 52:270-3. 2008
  65. ncbi Giant cell tumor of the distal radius
    D S Sheth
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Hand Surg Am 20:432-40. 1995
    ..En bloc excision with arthrodesis is more suitable for extensive local disease with poor residual bone stock and as salvage for failed intralesional excision...
  66. ncbi The use of fibular autograft and ankle arthrodesis for aggressive giant cell tumor in the distal tibia: a case report
    Yener Saglik
    Department of Orthopaedics and Traumatology, Ankara University School of Medicine, Ankara, Turkey
    Foot Ankle Int 29:438-41. 2008
    ..In conclusion, due to the large resection that is often necessary for aggressive tumors, fibular autograft and ankle arthrodesis may be a useful method in the distal tibia...
  67. ncbi Microsurgical fibular graft for full-length radius reconstruction after giant-cell tumor resection: a case report
    Guang Rong Yu
    Department of Orthopedic Surgery, Tongji Hospital, Tongji University, 389 Xincun Road, 200 065 Shanghai, China
    Microsurgery 25:121-5. 2005
    ..With appropriate dynamic tendon transfer, this procedure can provide an alternative method for reconstruction of the full-length radius after tumor resection, with functional and durable results...
  68. ncbi Giant cell tumor of the cervical spine: a series of 22 cases and outcomes
    Ma Junming
    The Spine Center, Changzheng Hospital, The Second Military Medical University, Shanghai, People s Republic of China
    Spine (Phila Pa 1976) 33:280-8. 2008
    ..A consecutive series of 22 giant cell tumor (GCTs) of the cervical spine which underwent surgical treatment was observed from 1990-2003...
  69. ncbi Autogenous fibular graft and silicone implant arthroplasty following resection of giant cell tumor of the metacarpal: a report of two cases
    E A Athanasian
    Department of Orthopedics, Mayo Clinic, Rochester, MN 55905, USA
    J Hand Surg Am 22:504-7. 1997
    ..At 2-year and 1-year follow-up evaluation, respectively, the patients were found to be doing well. This method of reconstruction appears reliable and presents the possibility for vascularized reconstruction if that is thought necessary...
  70. ncbi Giant cell tumor of bone in children and adolescents
    Ajay Puri
    Tata Memorial Hospital, Mumbai, India
    J Pediatr Orthop 27:635-9. 2007
    There are very few series that document giant cell tumor of bone (GCT) in the immature skeleton, and the reported incidence in literature varies from 1.8% to 10.6%...
  71. ncbi Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India
    R Gupta
    Department of Pathology, Tata Memorial Hospital, Parel, Mumbai 400012, India
    Ann Diagn Pathol 12:239-48. 2008
    Over 20 years, 470 cases of giant cell tumor of bone diagnosed at a tertiary cancer hospital were analyzed. Male predominance (57%), predilection for bones around the knee joint (42%), and occurence in the 21- to 30-year-old age group (49...
  72. ncbi Giant-cell tumors of the carpus
    Koji Shigematsu
    Department of Orthopaedic Surgery, Nara Medical University, Nara, Japan
    J Hand Surg Am 31:1214-9. 2006
    ..Intralesional procedures, such as curettage, were associated with a high incidence of recurrence (24%), whereas cases treated with an excisional procedure did not recur...
  73. ncbi Telomerase activity in giant cell tumors of bone
    Toshihiro Matsuo
    Department of Orthopaedic Surgery, Hiroshima University, 1 2 3 Kasumi, Minami Ku, Hiroshima, 734 8551, Japan
    Ann Surg Oncol 14:2896-902. 2007
    A giant cell tumor of bone (GCT) is a histologically benign neoplasma that has an unpredictable pattern of biological aggressiveness...
  74. ncbi Re-operation results in osteoarthritic change of knee joints in patients with giant cell tumor of bone
    Yoshitaka Suzuki
    Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya 466 8550, Japan
    Knee 14:369-74. 2007
    b>Giant cell tumor of bone occasionally results in secondary osteoarthritic changes in adjacent joints...
  75. ncbi Iatrogenic seeding of a giant cell tumor of the patella to the proximal tibia
    Onder Ofluoglu
    Department of Orthopedics, Lutfi Kirdar Research Hospital, Istanbul, Turkey
    Clin Orthop Relat Res 465:260-4. 2007
    ..The cause and prevention of implantation metastasis are discussed and the basic principles of musculoskeletal tumor management emphasized...
  76. ncbi Ankle arthrodesis with bone graft after distal tibia resection for bone tumors
    Domenico Andrea Campanacci
    Firenze, Italy
    Foot Ankle Int 29:1031-7. 2008
    ..Ankle arthrodesis has proven to be an effective treatment in primary and post-traumatic joint arthritis, but few papers have addressed the feasibility and techniques of ankle arthrodesis in tumor surgery after long bone resections...
  77. ncbi Cytotoxic effect of drugs eluted from polymethylmethacrylate on stromal giant-cell tumour cells: an in vitro study
    D Gouran Savadkoohi
    Pasteur Institute of Iran, Tehran, Iran
    J Bone Joint Surg Br 90:973-9. 2008
    ..Even in low doses, cytotoxic drugs mixed with polymethylmethacrylate cement could therefore be considered as effective local adjuvant treatment for GCTs...
  78. ncbi What's new in musculoskeletal oncology
    Valerae O Lewis
    MD Anderson Cancer Center, P.O. Box 301402, Unit 408, Houston, TX 77230-1402, USA
    J Bone Joint Surg Am 89:1399-407. 2007
  79. ncbi Management of grade III giant cell tumors of bones
    Hsien-Chung Wang
    Department of Orthopedic Surgery, Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
    J Surg Oncol 92:46-51. 2005
    ....
  80. ncbi Pulmonary metastases of giant cell tumour of the bone
    W I Faisham
    Musculoskeletal Oncology Unit, School of Medical Science, University Sains Malaysia, Kubang Kerian, Kelantan
    Med J Malaysia 59:78-81. 2004
    ..Early detection and treatment of this tumour is important as complete resection of this tumour have favourable prognosis. Multiple lung nodules which preclude resection may remain dormant and asymptomatic with systemic chemotherapy...
  81. ncbi Multifocal metachronous giant cell tumor in a 15-year-old boy
    Peter G Stratil
    Department of Radiology, University of Chicago Hospitals, MC 2026, 5841 South Maryland, Chicago, IL 60610, USA
    Pediatr Radiol 35:444-8. 2005
    ..Pediatric radiologists should be aware of this when encountering a single lesion with characteristic radiographic features of GCT and when encountering multiple lytic skeletal lesions...
  82. ncbi [Reconstruction of the distal radius for primary bone tumors using a non-vascularized fibular graft (report of 4 cases)]
    M Rtaimate
    Clinique Lille-Sud, SOS Mains, rue Gustave Delory, 59000 Lesquin, France
    Chir Main 20:272-9. 2001
    ..Bone graft healing occurred at a mean of six months with a range of from four to nine months. Resection followed by a non-vascularised fibular graft is an effective way to managing these patients...
  83. ncbi Giant cell tumor of the distal fibula: fifteen-year result after en bloc resection and fibula reconstruction
    Wolfgang Eger
    Department of Orthopaedic Surgery at Rummelsberg Hospital, Rummelsberg, Schwarzenbruck Nürnberg, Germany
    Arch Orthop Trauma Surg 124:56-9. 2004
    ..Giant cell tumor of the distal fibula is a very rare condition. The treatment of advanced tumors at this location can be challenging and has been described in the literature only in single cases...
  84. ncbi Bone imaging in "giant" giant cell tumor
    C P Wong
    Department of Nuclear Medicine, Queen Elizabeth Hospital, Hong Kong
    Clin Nucl Med 29:509-13. 2004
  85. ncbi Neoplastic and tumorlike lesions detected on MR imaging of the knee in patients with suspected internal derangement: Part I, intraosseous entities
    Gregory S Stacy
    Department of Radiology, The University of Chicago Hospitals, 5841 S. Maryland Ave, MC 2026, Chicago, IL 60637, USA
    AJR Am J Roentgenol 178:589-94. 2002
  86. ncbi [Giant cell tumor--osteoclastoma: part II]
    J Kordos
    , FN, SPAM, Bratislava
    Acta Chir Orthop Traumatol Cech 68:141-7. 2001
    ..In case of extensive destruction in the region of joints the method of choice is the application of both individual and total replacement...
  87. ncbi Giant cell tumour of the first metacarpal
    Abdul Basit
    Department of Orthopaedic Surgery, Liaquat National Hospital, Stadium Road, Karachi
    J Coll Physicians Surg Pak 14:374-5. 2004
    ..A case report of lytic lesion of the first metacarpal bone is presented, which was a conventional grade III giant cell tumour. It was excised and reconstructed by a free fibular graft with gratifying result after three years follow-up...
  88. ncbi Aneurysmal bone cyst: a hereditary disease?
    Andreas Leithner
    Department of Orthopaedic Surgery, Karl Franzens University, Auenbruggerplatz 9, A 8036 Graz, Austria
    J Pediatr Orthop B 13:214-7. 2004
    ..These data indicate that a predisposing genetic defect could be part of a multifactorial pathogenesis in the development of some aneurysmal bone cysts...
  89. ncbi [Limb salvage surgery for wrist in bone tumor by using free vascularised fibular graft with fibular head or simple fibular graft]
    Chao Qi
    Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 18:165-7. 2004
    ..So in the procedure for reconstruction and limb salvage after bone tumor resection of distal radius, the free vascularised fibular graft with fibular head is an ideal substitute...
  90. ncbi [Multicentric giant cell tumor of the upper arm]
    M Hamdi
    , , Tunisie
    Acta Orthop Belg 68:87-92. 2002
    ..The histologic study confirmed the diagnosis of giant cell tumor of similar grade. After 13 years follow-up, the patient had a satisfactory function of the limb and no recurrence of the tumor was noted...
  91. ncbi Management of the giant-cell tumours of the distal radius
    M T Khan
    Department of Orthopaedic Oncology, The Royal Orthopaedic Hospital, Birmingham, UK
    Ann R Coll Surg Engl 86:18-24. 2004
    ..In the present series, we report the results of curettage only as the treatment for primary giant-cell tumour of the distal radius carried out at a single centre...
  92. ncbi Subchondral giant-cell tumor of the proximal tibia: arthroscopic treatment for accelerated articular cartilage and meniscal degeneration in two patients
    Samir G Tejwani
    Department of Orthopaedic Surgery, University of California, Los Angeles School of Medicine, Los Angeles, California 90095, USA
    Arthroscopy 20:644-9. 2004
    ..Repetitive heavy loading of the knee, such as running, was prohibited, and long-term follow-up is warranted to assess for further joint degeneration and need for total knee arthroplasty...
  93. ncbi Reconstruction of the distal radius by fibula following excision of giant cell tumor
    V K Aithal
    Department of Orthopedics, Nizwa Hospital, P O Box 1222, Sultanate of Oman
    Int Orthop 27:110-3. 2003
    ..2 months. The surgical technique using a radiofibular plate and K wire through the wrist had a low nonunion rate, no graft related complications, good range of movement, and good hand functions...
  94. ncbi Giant cell tumor of bone
    Alan W Yasko
    Department of Orthopedic Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, TX 77030, USA
    Curr Oncol Rep 4:520-6. 2002
    b>Giant cell tumor of bone is an enigmatic osseous neoplasm that is histologically benign but clinically shows local aggression and metastatic potential...
  95. ncbi Fine needle aspiration cytology diagnosis of pulmonary metastasis from giant-cell tumour of bone
    Babu Nagesh
    Cytopathology 13:256-7. 2002
  96. ncbi Fibulo-scapho-lunate arthrodesis as a motion-preserving procedure after tumour resection of the distal radius
    B Bickert
    Department of Hand, Plastic and Reconstructive Surgery, BG Trauma Center Ludwigshafen, Germany
    J Hand Surg Br 27:573-6. 2002
    ..Fibulo-scapho-lunate fusion represents an alternative. This reconstruction in two patients provided excellent wrist stability and a functional range of midcarpal motion...
  97. ncbi Radiologic case study. Giant-cell tumor of the wrist in a skeletally immature girl
    Jérĵme Cottalorda
    Department of Orthopedic Pediatric Surgery, University School of Medicine, Saint Etienne, France
    Orthopedics 25:470, 550-2. 2002
  98. ncbi Vascularized fibular graft after excision of giant-cell tumor of the distal radius: wrist arthroplasty versus partial wrist arthrodesis
    Akio Minami
    Department of Orthopaedic Surgery, Hokkaido University School of Medicine, Kita 15, Nishi 7, Kita ku Sapporo, Hokkaido 060 8638, Japan
    Plast Reconstr Surg 110:112-7. 2002
    ....
  99. ncbi Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results
    K Szalay
    Orthopaedic Clinic of Semmelweis University, Budapest, Hungary
    Int Orthop 30:505-9. 2006
    ....
  100. ncbi Allograft replacement in limb salvage surgery for bone tumors
    P Itiravivong
    Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    J Med Assoc Thai 84:S396-400. 2001
    ..Though psychosocial benefit was gained in patients with this limb salvage procedure, functional evaluation did not yield a satisfactory result...
  101. ncbi Principles of limb salvage surgery of the upper extremity
    Michael E Leit
    Department of Orthopaedic Surgery, University of Rochester Medical Center, 601 Elmwood Avenue, Box 665, Rochester, NY 14642, USA
    Hand Clin 20:v, 167-79. 2004
    ..Because preservation of hand function, even modest levels thereof, is clearly superior to amputation from a functional standpoint, the authors review the principles of limb salvage in this article...

Research Grants23

  1. Molecular Mechanisms in Bone Resorption
    STEVEN LIETMAN; Fiscal Year: 2009
    ..New information about mechanisms of bone resorption may facilitate the development of novel strategies to decrease bone resorption and may lead to new treatments for osteoporosis. ..
  2. RANK-Associated Inhibitor (RAIN) in Osteoclast Formation
    Bryant Darnay; Fiscal Year: 2007
    ..and have been implicated in various diseases, which include rheumatoid arthritis, osteoporosis, giant cell tumor of bone, Paget's disease, metastatic breast cancer, multiple myeloma, and familial expansile osteolysis...
  3. Bioengineering Annulus Fibrosus using Silk Scaffold
    Rita Kandel; Fiscal Year: 2006
    ..The viability and mechanical properties of the tissue will be evaluated. ..
  4. Molecular Mechanisms of Ectopic Bone Formation
    STEVEN LIETMAN; Fiscal Year: 2006
    ..abstract_text> ..
  5. METABOLISM IN NORMAL AND OSTEOARTHRITIC CARTILAGE
    Henry Mankin; Fiscal Year: 1991
    ..The receptors for this cytokine on normal and OA chondrocytes will be quantitated. Further definition of these cartilage metabolic pathways are of primary importance in our understanding of osteoarthritis...
  6. Minimally Invasive Approaches for Craniofacial Surgery
    Maria Troulis; Fiscal Year: 2005
    ..abstract_text> ..
  7. INVESTIGATING THE MECHANISMS OF PRB TUMOR SUPPRESSION
    Arnab Chakravarti; Fiscal Year: 2003
    ..Specific Aim number 3: To determine whether the deregulation of E2F dependent transcription is correlated with the tumorigenic potential of RB -/- cells in-vivo. ..
  8. METABOLISM IN NORMAL AND OSTEOARTHRITIC CARTILAGE
    Henry Mankin; Fiscal Year: 2001
    ..It is further speculated that the study of serine proteinases produced by OA cartilage may have strong implications for the management of this debilitating disease. ..
  9. Molecular Mechanisms in Bone Resorption
    Steven A Lietman; Fiscal Year: 2010
    ..New information about mechanisms of bone resorption may facilitate the development of novel strategies to decrease bone resorption and may lead to new treatments for osteoporosis. ..